ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

METXF Me Therapeutics Holdings Inc (PK)

0.00
0.00 (0.00%)

Me Therapeutics (PK) Financial Summary

The current METXF market cap is 0. The company's latest EPS is CAD and P/E is N/A.

Year End 31 August 2023 20222023
CAD ($)CAD ($)
Total Revenue 00
Operating Income -70k-640k
Net Income -145k-6.52M
Year End 31 August 2023 20222023
CAD ($)CAD ($)
Total Assets 102k672k
Total Liabilities 233k149k
Total Equity -131k523k

Cash Flow

Year End 31 August 2023 20222023
CAD ($)CAD ($)
Operating -136k-303k
Investing N/A 757k
Financing 140k116k
Market Cap 0
Price to Earnings Ratio N/A
Price to Sales Ratio 0
Price to Cash Ratio 0
Price to Book Ratio 0
Dividend Yield -

Share Statistics

Shares Outstanding 23.56M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0 (0%)

Company Info

Company Name Me Therapeutics Holdings Inc (PK)
Address 177 robson street
vancouver, british columbia V6C 0A3.
Website https://www.metherapeutics.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock